Diminution in flow following primary stenting in the INAMI study.
Murphy
Sabina A
SA
Gibson
C Michael
CM
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods; D001783:Blood Flow Velocity; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000188:drug therapy* / Q000517:prevention & control; D000077542:Eptifibatide; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000628:therapy*; D010455:Peptides / Q000008:administration & dosage*; D011292:Premedication; D011336:Probability; D018570:Risk Assessment; D015607:Stents; D016896:Treatment Outcome; D014654:Vascular Patency / Q000187:drug effects
D010455:Peptides; D000077542:Eptifibatide